• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 相关头痛特征的病例系列:头痛可能是孤立的症状。

Case Series of Headache Characteristics in COVID-19: Headache Can Be an Isolated Symptom.

机构信息

Department of Neurology & Algology, Gazi University Hospital, Ankara, Turkey.

出版信息

Headache. 2020 Sep;60(8):1788-1792. doi: 10.1111/head.13940. Epub 2020 Aug 17.

DOI:10.1111/head.13940
PMID:32790216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7436308/
Abstract

Headache was reported in up to one-third of the hospitalized patients; yet, the clinical characteristics of headache associated with coronavirus disease 2019 (COVID-19) have not been defined. This observational case study included patients who were consulted to headache unit due to headache and had COVID-19 illness. Headache features in 13 PCR-confirmed COVID-19 patients with mild symptoms were reported. Headache was the isolated symptom of the COVID-19 in 3 patients and emerged as an early symptom during the disease course in all patients. Patients specified severe, rapid onset, unrelenting headache with migraine-like features, as well as unusual sensory symptoms such as anosmia, and gastrointestinal symptoms such as diarrhea and loss of appetite and weight. Headache lasted up to 3 days in 70% of the patients and resolved in all patients within 2 weeks. Despite the fact that most of the patients were female and headache characteristics were suggestive of migraine, majority of patients were not suffering from primary headaches. It was concluded that headache could be an isolated symptom of COVID-19, which might possibly be ignored in asymptomatic patients. Headaches associated with COVID-19 included features resembling migraine and/or atypical symptoms including anosmia and diarrhea.

摘要

多达三分之一的住院患者会出现头痛;然而,与 2019 年冠状病毒病(COVID-19)相关的头痛的临床特征尚未确定。这项观察性病例研究纳入了因头痛而到头痛科就诊且患有 COVID-19 的患者。报告了 13 名经 PCR 确诊的 COVID-19 轻症患者的头痛特征。3 名患者的 COVID-19 仅表现为头痛,所有患者的头痛均为疾病早期出现的症状。患者具体描述为严重、快速发作、持续不断的头痛,具有偏头痛样特征,以及不常见的感觉症状,如嗅觉丧失,以及胃肠道症状,如腹泻、食欲不振和体重减轻。70%的患者头痛持续长达 3 天,所有患者均在 2 周内缓解。尽管大多数患者为女性,且头痛特征提示偏头痛,但大多数患者并非原发性头痛。研究得出结论,头痛可能是 COVID-19 的孤立症状,在无症状患者中可能会被忽视。COVID-19 相关头痛包括类似于偏头痛的特征和/或不典型症状,包括嗅觉丧失和腹泻。

相似文献

1
Case Series of Headache Characteristics in COVID-19: Headache Can Be an Isolated Symptom.COVID-19 相关头痛特征的病例系列:头痛可能是孤立的症状。
Headache. 2020 Sep;60(8):1788-1792. doi: 10.1111/head.13940. Epub 2020 Aug 17.
2
Headache as the Presenting Symptom in 2 Patients With COVID-19 and a History of Migraine: 2 Case Reports.COVID-19 病史患者头痛为首发症状 2 例:2 例病例报告
Headache. 2020 Sep;60(8):1773-1776. doi: 10.1111/head.13890. Epub 2020 Jul 3.
3
Spectrum of Headaches Associated With SARS-CoV-2 Infection: Study of Healthcare Professionals.与 SARS-CoV-2 感染相关的头痛谱:医护专业人员研究。
Headache. 2020 Sep;60(8):1697-1704. doi: 10.1111/head.13902. Epub 2020 Jul 15.
4
Persistent Headache and Persistent Anosmia Associated With COVID-19.与新冠病毒相关的持续性头痛和持续性嗅觉丧失
Headache. 2020 Sep;60(8):1797-1799. doi: 10.1111/head.13941. Epub 2020 Aug 26.
5
Frequency and Type of Red Flags in Patients With Covid-19 and Headache: A Series of 104 Hospitalized Patients.新冠病毒感染后头痛患者的“红色警报”频率和类型:104 例住院患者系列。
Headache. 2020 Sep;60(8):1664-1672. doi: 10.1111/head.13927. Epub 2020 Aug 18.
6
COVID-19 and Headache: A Primer for Trainees.COVID-19 与头痛:医学生入门指南。
Headache. 2020 Sep;60(8):1806-1811. doi: 10.1111/head.13884. Epub 2020 Jun 19.
7
Headache characteristics in COVID-19 pandemic-a survey study.新冠疫情期间的头痛特征:一项调查研究。
J Headache Pain. 2020 Oct 13;21(1):121. doi: 10.1186/s10194-020-01188-1.
8
Headache as a Cardinal Symptom of Coronavirus Disease 2019: A Cross-Sectional Study.头痛为 2019 冠状病毒病的主要症状:一项横断面研究。
Headache. 2020 Nov;60(10):2176-2191. doi: 10.1111/head.13967. Epub 2020 Sep 28.
9
Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19.三叉神经系统的激活可能是 COVID-19 患者嗅觉丧失的原因之一,而 SARS-CoV-2 可能是其作用靶点。
Cephalalgia. 2022 Feb;42(2):176-180. doi: 10.1177/03331024211036665. Epub 2021 Aug 18.
10
Comparison of Hospitalized COVID-19 Patients in Terms of Disease Course According to the Presence of Gastrointestinal Symptoms Before and After Admission.比较 COVID-19 住院患者入院前后出现胃肠道症状的疾病进程。
Turk J Gastroenterol. 2023 Apr;34(4):322-331. doi: 10.5152/tjg.2023.22003.

引用本文的文献

1
Incidence of Neurological Manifestations in Critically Ill COVID-19 Patients: A Low-Resource Setting Experience.重症 COVID-19 患者神经系统表现的发生率:低资源环境下的经验
Cureus. 2025 Jun 9;17(6):e85616. doi: 10.7759/cureus.85616. eCollection 2025 Jun.
2
New insights into the increased risk of migraines from COVID-19 infection and vaccination: a Mendelian randomization study.新冠病毒感染和疫苗接种导致偏头痛风险增加的新见解:一项孟德尔随机化研究
Front Neurol. 2024 Oct 25;15:1445649. doi: 10.3389/fneur.2024.1445649. eCollection 2024.
3
Neurological manifestations of COVID-19 in Indonesia: Assessment of the role of sex and age.印度尼西亚新冠肺炎的神经学表现:性别和年龄作用的评估
Narra J. 2023 Dec;3(3):e277. doi: 10.52225/narra.v3i3.277. Epub 2023 Dec 20.
4
Role of TNF in the Pathogenesis of Migraine.TNF 在偏头痛发病机制中的作用。
Pain Res Manag. 2024 Jan 3;2024:1377143. doi: 10.1155/2024/1377143. eCollection 2024.
5
Emerging Landscape of Preclinical Models for Studying COVID-19 Neurologic Diseases.用于研究新冠病毒神经疾病的临床前模型的新态势
ACS Pharmacol Transl Sci. 2023 Sep 6;6(10):1323-1339. doi: 10.1021/acsptsci.3c00127. eCollection 2023 Oct 13.
6
Headache in COVID-19 and Long COVID: to Know Facts for Clinical Practice.新冠病毒感染及新冠后综合征中的头痛:临床实践需了解的事实
Curr Neurol Neurosci Rep. 2023 Oct;23(10):551-560. doi: 10.1007/s11910-023-01296-w. Epub 2023 Sep 4.
7
Neurological and Psychiatric Manifestations of Long COVID-19 and Their [F]FDG PET Findings: A Review.新冠长期症状的神经和精神表现及其[F]FDG PET检查结果:综述
Diagnostics (Basel). 2023 Jul 12;13(14):2353. doi: 10.3390/diagnostics13142353.
8
Aged brain and neuroimmune responses to COVID-19: post-acute sequelae and modulatory effects of behavioral and nutritional interventions.衰老大脑与对新冠病毒的神经免疫反应:急性后遗症以及行为和营养干预的调节作用
Immun Ageing. 2023 Apr 12;20(1):17. doi: 10.1186/s12979-023-00341-z.
9
Headache Characteristics of Patients with COVID-19 in Turkey: Is COVID-19 Infection a Trigger for Migraine Headache?土耳其新冠肺炎患者的头痛特征:新冠肺炎感染是偏头痛的诱发因素吗?
Noro Psikiyatr Ars. 2023 Feb 20;60(1):81-86. doi: 10.29399/npa.28141. eCollection 2023.
10
Results of a Web-Based Survey on 2105 Greek Migraine Patients-Second Part: Efficacy of Acute and Prophylactic Migraine Treatments and Corresponding Patients' Reported Satisfaction.基于网络的 2105 例希腊偏头痛患者调查结果-第二部分:急性和预防性偏头痛治疗的疗效及相应患者报告的满意度。
Medicina (Kaunas). 2022 Dec 23;59(1):31. doi: 10.3390/medicina59010031.

本文引用的文献

1
SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)受体和进入基因在人嗅神经上皮和大脑中表达。
iScience. 2020 Dec 18;23(12):101839. doi: 10.1016/j.isci.2020.101839. Epub 2020 Nov 25.
2
Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia.SARS-CoV-2 进入基因在嗅觉系统中的非神经元表达提示了 COVID-19 相关嗅觉丧失的潜在机制。
Sci Adv. 2020 Jul 31;6(31). doi: 10.1126/sciadv.abc5801. Epub 2020 Jul 24.
3
Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia.一名2019冠状病毒病(COVID-19)合并嗅觉丧失患者的脑磁共振成像改变
JAMA Neurol. 2020 Aug 1;77(8):1028-1029. doi: 10.1001/jamaneurol.2020.2125.
4
Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.新型冠状病毒病 2019 时代冠状病毒的神经发病机制和神经表现:综述。
JAMA Neurol. 2020 Aug 1;77(8):1018-1027. doi: 10.1001/jamaneurol.2020.2065.
5
COVID-19 is a Real Headache!COVID-19 真是让人头疼!
Headache. 2020 Jul;60(7):1415-1421. doi: 10.1111/head.13856. Epub 2020 May 27.
6
Could CGRP Antagonists Be Helpful in the Fight Against COVID-19?降钙素基因相关肽拮抗剂在抗击新冠病毒肺炎中会有帮助吗?
Headache. 2020 Jul;60(7):1450-1452. doi: 10.1111/head.13853. Epub 2020 Jun 15.
7
Strong associations and moderate predictive value of early symptoms for SARS-CoV-2 test positivity among healthcare workers, the Netherlands, March 2020.2020 年 3 月,荷兰医护人员的早期症状与 SARS-CoV-2 检测阳性结果有很强的关联性和中等的预测价值。
Euro Surveill. 2020 Apr;25(16). doi: 10.2807/1560-7917.ES.2020.25.16.2000508.
8
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.中国武汉住院的 2019 年冠状病毒病患者的神经系统表现。
JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.
9
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms.74 例伴有胃肠道症状的 2019 年冠状病毒病(COVID-19)患者的流行病学、临床和病毒学特征。
Gut. 2020 Jun;69(6):1002-1009. doi: 10.1136/gutjnl-2020-320926. Epub 2020 Mar 24.
10
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)进入细胞依赖于 ACE2 和 TMPRSS2,可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.